Regeneron Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
31.03.25
/
50%
€586.00
Target price
31.03.26
€922.40
Performance (%)
4.82%
Price
15:38
€611.60
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 4.82%. Dividends of €2.64 are taken into consideration when calculating the performance. This prediction currently runs until 31.03.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | -8.323% | -8.323% |
| iShares Core DAX® | 0.760% | 1.149% |
| iShares Nasdaq 100 | 0.732% | 1.884% |
| iShares Nikkei 225® | 1.025% | -0.865% |
| iShares S&P 500 | -0.036% | 1.480% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at JPMorgan Chase & Co. from $1,100.00 to $1,000.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€444.50
09.06.25
09.06.25
€700.56
09.06.26
09.06.26
39.79%
15:38
15:38
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€872.60
24.10.24
24.10.24
€1,064.9
24.10.25
24.10.25
-42.87%
25.10.25
25.10.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€990.00
02.08.24
02.08.24
€1,099.6
02.08.25
02.08.25
-51.29%
03.08.25
03.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€974.20
17.06.24
17.06.24
€1,072.3
17.06.25
17.06.25
-54.45%
18.06.25
18.06.25